129 related articles for article (PubMed ID: 38205615)
1. Assessing the time-to-removal of totally implantable venous access devices comparing valved-versus open-ended catheters in patients treated with chemotherapy.
Amroun K; Brugel M; Rhaiem R; Teuma L; Vannieuwenhuyse G; Lipere A; Brenet E; Kianmanesh R; Bouché O
J Vasc Access; 2024 Jan; ():11297298231223539. PubMed ID: 38205615
[TBL] [Abstract][Full Text] [Related]
2. Complications related to totally implantable venous access devices in children and adults following lung transplantation.
Cho JK; Acord M; Goldfarb SB; Reddy SN; Goldberg HJ; Courtwright AM
Clin Transplant; 2019 Feb; 33(2):e13465. PubMed ID: 30561770
[TBL] [Abstract][Full Text] [Related]
3. Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution.
Choksi A; Finnegan K; Etezadi V
Am J Infect Control; 2020 Jan; 48(1):95-99. PubMed ID: 31439370
[TBL] [Abstract][Full Text] [Related]
4. Availability of totally implantable venous access devices in cancer patients is high in the long term: a seven-year follow-up study.
Tumay LV; Guner OS
Support Care Cancer; 2021 Jul; 29(7):3531-3538. PubMed ID: 33155092
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of totally implantable venous access devices.
Wang YC; Lin PL; Chou WH; Lin CP; Huang CH
Support Care Cancer; 2017 Jul; 25(7):2049-2054. PubMed ID: 28181014
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized study assessing different modalities for flushing totally implanted vascular access device in children with malignancy.
Hsieh HC; Hung SC; Huang SY; Huang FL; Chou CM
J Chin Med Assoc; 2022 Jan; 85(1):114-119. PubMed ID: 34407037
[TBL] [Abstract][Full Text] [Related]
7. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
Wilson GJ; van Noesel MM; Hop WC; van de Ven C
J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of catheter-related thrombosis in early-stage breast cancer patients: a single-center retrospective study.
Tan L; Sun Y; Zhu L; Lei X; Liang D; Rao N; Su F; Chen K; Li S
Cancer Manag Res; 2019; 11():8379-8389. PubMed ID: 31571994
[TBL] [Abstract][Full Text] [Related]
10. Difficult removal of totally implantable venous access devices in adult patients: Incidence, risk factors, and management.
Chatani S; Tsukii R; Nagasawa K; Hasegawa T; Murata S; Kato M; Yamaura H; Onaya H; Matsuo K; Watanabe Y; Inaba Y
J Vasc Access; 2023 Sep; 24(5):1150-1157. PubMed ID: 35081814
[TBL] [Abstract][Full Text] [Related]
11. Maintaining patency in totally implantable venous access devices (TIVAD): a time-to-event analysis of different lock irrigation intervals.
Palese A; Baldassar D; Rupil A; Bonanni G; Capellari Maria T; Contessi D; De Crignis L; Vidoni A; Piller Roner S; Zanini A
Eur J Oncol Nurs; 2014 Feb; 18(1):66-71. PubMed ID: 24100090
[TBL] [Abstract][Full Text] [Related]
12. Comparison of peripherally inserted central catheters and totally implanted venous access devices as chemotherapy delivery routes in oncology patients: A retrospective cohort study.
Yun WS; Yang SS
Sci Prog; 2021; 104(2):368504211011871. PubMed ID: 33950754
[TBL] [Abstract][Full Text] [Related]
13. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.
Singh KR; Agarwal G; Nanda G; Chand G; Mishra A; Agarwal A; Verma AK; Mishra SK; Goyal P
World J Surg; 2014 May; 38(5):1084-92. PubMed ID: 24305930
[TBL] [Abstract][Full Text] [Related]
14. Radio-opacity and incidental identified mechanical complications of totally implantable venous access devices placed in the chest.
Surov A; Rusner C; Weigand K; John E; Spielmann RP; Behrmann C
Acta Radiol; 2012 Nov; 53(9):1035-9. PubMed ID: 23028172
[TBL] [Abstract][Full Text] [Related]
15. Transesophageal echocardiography-guided implantation of totally implantable venous access devices via the internal jugular vein: retrospective analysis of 297 cases in pediatric patients.
Chen Y; Xing D; Wu L; Lin H; Lin T; Ding F; Xu L
World J Surg Oncol; 2022 Aug; 20(1):272. PubMed ID: 36042478
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
Lee JK; Choi YB
J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
[TBL] [Abstract][Full Text] [Related]
17. Catheter-related Complications of Subcutaneous Implantable Venous Access Devices in Breast Cancer Patients.
El-Balat A; Schmeil I; Karn T; Holtrich U; Mavrova-Risteska L; Rody A; Youssef A; Hanker LC
In Vivo; 2018; 32(5):1275-1281. PubMed ID: 30150457
[TBL] [Abstract][Full Text] [Related]
18. Internal jugular vein versus subclavian vein as the percutaneous insertion site for totally implantable venous access devices: a meta-analysis of comparative studies.
Wu S; Huang J; Jiang Z; Huang Z; Ouyang H; Deng L; Lin W; Guo J; Zeng W
BMC Cancer; 2016 Sep; 16(1):747. PubMed ID: 27658952
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for central venous port failure in cancer patients.
Hsieh CC; Weng HH; Huang WS; Wang WK; Kao CL; Lu MS; Wang CS
World J Gastroenterol; 2009 Oct; 15(37):4709-14. PubMed ID: 19787834
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors of the Totally Implantable Venous Access Device-Related Infection in Patients With Brain Tumors Undergoing Chemotherapy After Surgery.
Li H; Shan J
Surg Infect (Larchmt); 2024 Mar; 25(2):133-139. PubMed ID: 38265425
[No Abstract] [Full Text] [Related]
[Next] [New Search]
